The Translational Genomics Research Institute and the Van Andel Research Institute, in partnership with the National Cancer Institute, the University of Pennsylvania, and Michigan State University, have created the Canine Hereditary Cancer Consortium to better understand cancer in dogs and humans.
The research features an unprecedented collaboration of veterinarians, scientists, research institutes, government entities, and corporations to accelerate the development of a cure.
By using the DNA in canine saliva, blood, and tumor samples, the scientists hope to better understand the genetic causes of cancer that will lead to treatment for both humans and canines. Having access to canine samples will allow researchers to study diseases, like sarcomas, where the scarcity of human samples makes it difficult to study.
The Canine Hereditary Cancer Consortium will be funded by a 2-year, $4.3 million federal stimulus grant and an additional $1 million provided by PetSmart and Hill’s Pet Nutrition. The research is also endorsed by the American Kennel Club and the Morris Animal Foundation
In addition to cancer, TGen and VARI eventually will study neurological and behavioral disorders as well as hearing loss and other debilitative conditions.